Loading...
Market
Will UCSF's metagenomic test receive FDA approval by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA announcements and official approval documents
Story
UCSF's Metagenomic Test Achieves 86% Accuracy in CNS Infection Diagnosis in Thousands Over Seven Years, Published in Nature Medicine
Nov 12, 2024, 03:40 PM
A clinical metagenomic next-generation sequencing test developed at the University of California, San Francisco (UCSF) has demonstrated a seven-year performance in diagnosing central nervous system infections. The test has been validated in thousands of patients, showing an accuracy rate of 86% in identifying diverse pathogens. This advancement is significant for improving patient care in neurological infections and enhancing detection capabilities for pandemic threats. The findings were reported in prominent medical journals, including Nature Medicine and Nature Communications.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Guardant Reveal • 25%
Guardant360 • 25%
GuardantOMNI • 25%
None • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
